|
March 31,
|
December 31,
|
|||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Current assets
|
||||||||
|
Cash and cash equivalents
|
1,772
|
1,478
|
||||||
|
Trade receivables
|
122
|
137
|
||||||
|
Short-term derivative instruments
|
-
|
16
|
||||||
|
Other investments
|
96
|
107
|
||||||
|
Other current assets
|
42
|
65
|
||||||
|
Total current assets
|
2,032
|
1,803
|
||||||
|
Non-current assets
|
||||||||
|
Investment in OPC’s associated companies
|
1,348
|
1,626
|
||||||
|
Long-term restricted cash
|
165
|
164
|
||||||
|
Long-term derivative instruments
|
13
|
13
|
||||||
|
Deferred taxes, net
|
11
|
10
|
||||||
|
Property, plant and equipment, net
|
2,391
|
1,372
|
||||||
|
Intangible assets, net
|
84
|
83
|
||||||
|
Long-term prepaid expenses and other non-current assets
|
19
|
108
|
||||||
|
Right-of-use assets, net
|
333
|
201
|
||||||
|
Total non-current assets
|
4,364
|
3, 577
|
||||||
|
Total assets
|
6,396
|
5,380
|
||||||
|
Current liabilities
|
||||||||
|
Current maturities of loans from banks and others
|
145
|
117
|
||||||
|
Trade and other payables
|
353
|
245
|
||||||
|
Short-term derivative instruments
|
28
|
-
|
||||||
|
Current maturities of lease liabilities
|
17
|
3
|
||||||
|
Total current liabilities
|
543
|
365
|
||||||
|
Non-current liabilities
|
||||||||
|
Long-term loans from banks and others
|
1,661
|
1,142
|
||||||
|
Debentures
|
475
|
510
|
||||||
|
Deferred taxes, net
|
167
|
162
|
||||||
|
Other non-current liabilities
|
64
|
8
|
||||||
|
Long-term derivative instruments
|
9
|
|||||||
|
Long-term lease liabilities
|
163
|
8
|
||||||
|
Total non-current liabilities
|
2,539
|
1, 830
|
||||||
|
Total liabilities
|
3,082
|
2,195
|
||||||
|
Equity
|
||||||||
|
Share capital
|
50
|
50
|
||||||
|
Translation reserve
|
38
|
36
|
||||||
|
Capital reserve
|
42
|
48
|
||||||
|
Accumulated profit
|
1,371
|
1,455
|
||||||
|
Equity attributable to owners of the Company
|
1,501
|
1,589
|
||||||
|
Non-controlling interests
|
1,813
|
1,596
|
||||||
|
Total equity
|
3,314
|
3,185
|
||||||
|
Total liabilities and equity
|
6,396
|
5,380
|
||||||
|
For the three months ended
March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Revenue
|
317
|
183
|
||||||
|
Cost of sales and services (excluding depreciation and amortization)
|
(245
|
)
|
(139
|
)
|
||||
|
Depreciation and amortization
|
(25
|
)
|
(17
|
)
|
||||
|
Gross profit
|
47
|
27
|
||||||
|
Selling, general and administrative expenses
|
(26
|
)
|
(18
|
)
|
||||
|
Other expenses, net
|
(17
|
)
|
-
|
|||||
|
Operating profit
|
4
|
9
|
||||||
|
Financing expenses
|
(31
|
)
|
(23
|
)
|
||||
|
Financing income
|
36
|
12
|
||||||
|
Financing income/(expenses), net
|
5
|
(11
|
)
|
|||||
|
Share in profit of OPC’s associated companies, net
|
34
|
38
|
||||||
|
Profit before income taxes
|
43
|
36
|
||||||
|
Income tax expense
|
(9
|
)
|
(9
|
)
|
||||
|
Profit for the period
|
34
|
27
|
||||||
|
Attributable to:
|
||||||||
|
Kenon’s shareholders
|
26
|
12
|
||||||
|
Non-controlling interests
|
8
|
15
|
||||||
|
Profit for the period
|
34
|
27
|
||||||
|
Basic/diluted profit per share attributable to Kenon’s shareholders (in dollars):
|
||||||||
|
Basic/diluted profit per share
|
0.49
|
0.22
|
||||||
|
For the three months ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Cash flows from operating activities
|
||||||||
|
Profit for the period
|
34
|
27
|
||||||
|
Adjustments:
|
||||||||
|
Depreciation and amortization
|
26
|
19
|
||||||
|
Financing (income)/expenses, net
|
(5
|
)
|
11
|
|||||
|
Share in profit of associated companies, net
|
(34
|
)
|
(38
|
)
|
||||
|
Share-based payments
|
5
|
-
|
||||||
|
Other expenses, net
|
22
|
3
|
||||||
|
Income tax expense
|
9
|
9
|
||||||
|
57
|
31
|
|||||||
|
Change in trade and other receivables
|
26
|
3
|
||||||
|
Change in trade and other payables
|
(50
|
)
|
12
|
|||||
|
Payment under CPV Group’s profit participation plan
|
(70
|
)
|
-
|
|||||
|
Cash (used in)/generated from operating activities
|
(37
|
)
|
46
|
|||||
|
Income taxes paid, net
|
(2
|
)
|
-
|
|||||
|
Dividends received from associate companies, net
|
21
|
16
|
||||||
|
Net cash (used in)/provided by operating activities
|
(18
|
)
|
62
|
|||||
|
For the three months ended
March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Cash flows from investing activities
|
||||||||
|
Short-term deposits and restricted cash, net
|
(1
|
)
|
-
|
|||||
|
Investment in associated companies, less cash acquired
|
(77
|
)
|
(77
|
)
|
||||
|
Acquisition of property, plant and equipment
|
(126
|
)
|
(13
|
)
|
||||
|
Acquisition of non-controlling interest
|
(8
|
)
|
-
|
|||||
|
Acquisition of subsidiaries, less cash acquired
|
64
|
-
|
||||||
|
Proceeds from other investments
|
12
|
14
|
||||||
|
Proceeds from equity-accounted investee company capital distribution
|
11
|
-
|
||||||
|
Long-term loan repayment from an equity-accounted investee company
|
29
|
-
|
||||||
|
Interest received
|
22
|
11
|
||||||
|
Proceeds from transactions in derivatives not for hedging, net
|
34
|
-
|
||||||
|
Net cash used in investing activities
|
(40
|
)
|
(65
|
)
|
||||
|
Cash flows from financing activities
|
||||||||
|
Repayment of long-term loans, debentures and lease liabilities
|
(58
|
)
|
(44
|
)
|
||||
|
Investments of holders of non-controlling interests in the capital of a subsidiary
|
309
|
5
|
||||||
|
Proceeds from long-term loans
|
120
|
43
|
||||||
|
Repurchase of own shares
|
-
|
(10
|
)
|
|||||
|
Proceeds from short-term loans
|
5
|
-
|
||||||
|
Interest paid
|
(29
|
)
|
(16
|
)
|
||||
|
Net cash generated from/(used in) financing activities
|
347
|
(22
|
)
|
|||||
|
Increase/(decrease) in cash and cash equivalents
|
289
|
(25
|
)
|
|||||
|
Cash and cash equivalents at beginning of the year
|
1,478
|
1,016
|
||||||
|
Effect of exchange rate fluctuations on balances of cash and cash equivalents
|
5
|
(4
|
)
|
|||||
|
Cash and cash equivalents at end of the period
|
1,772
|
987
|
||||||
|
For the three months ended March 31, 2026
|
||||||||||||||||
|
OPC Israel
|
CPV Group
|
Other
|
Consolidated Results
|
|||||||||||||
|
$ millions
|
||||||||||||||||
|
Revenue
|
181
|
136
|
-
|
317
|
||||||||||||
|
Cost of sales (excluding depreciation and amortization)
|
(131
|
)
|
(114
|
)
|
-
|
(245
|
)
|
|||||||||
|
Depreciation and amortization
|
(18
|
)
|
(8
|
)
|
-
|
(26
|
)
|
|||||||||
|
Financing income
|
5
|
6
|
25
|
36
|
||||||||||||
|
Financing expenses
|
(17
|
)
|
(14
|
)
|
-
|
(31
|
)
|
|||||||||
|
Share in profit of associated companies
|
-
|
34
|
-
|
34
|
||||||||||||
|
Profit before taxes
|
10
|
9
|
24
|
43
|
||||||||||||
|
Income tax expense
|
(6
|
)
|
-
|
(3
|
)
|
(9
|
)
|
|||||||||
|
Profit for the period
|
4
|
9
|
21
|
34
|
||||||||||||
|
For the three months ended March 31, 2025
|
||||||||||||||||
|
OPC Israel
|
CPV Group
|
Other
|
Consolidated Results
|
|||||||||||||
|
$ millions
|
||||||||||||||||
|
Revenue
|
146
|
37
|
-
|
183
|
||||||||||||
|
Cost of sales (excluding depreciation and amortization)
|
(105
|
)
|
(34
|
)
|
-
|
(139
|
)
|
|||||||||
|
Depreciation and amortization
|
(19
|
)
|
-
|
-
|
(19
|
)
|
||||||||||
|
Financing income
|
1
|
2
|
9
|
12
|
||||||||||||
|
Financing expenses
|
(14
|
)
|
(2
|
)
|
(7
|
)
|
(23
|
)
|
||||||||
|
Share in profit of associated companies
|
-
|
38
|
-
|
38
|
||||||||||||
|
Profit before taxes
|
5
|
28
|
3
|
36
|
||||||||||||
|
Income tax expense
|
(2
|
)
|
(5
|
)
|
(2
|
)
|
(9
|
)
|
||||||||
|
Profit for the period
|
3
|
23
|
1
|
27
|
||||||||||||
|
For the three months ended March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Revenue
|
317
|
183
|
||||||
|
Cost of sales (excluding depreciation and amortization)
|
(245
|
)
|
(139
|
)
|
||||
|
Depreciation and amortization
|
(24
|
)
|
(17
|
)
|
||||
|
Gross profit
|
48
|
27
|
||||||
|
Selling, general and administrative expenses
|
(25
|
)
|
(17
|
)
|
||||
|
Other expenses, net
|
(17
|
)
|
(3
|
)
|
||||
|
Operating profit
|
6
|
7
|
||||||
|
Financing expenses
|
(31
|
)
|
(16
|
)
|
||||
|
Financing income
|
11
|
3
|
||||||
|
Financing expenses, net
|
(20
|
)
|
(13
|
)
|
||||
|
Share in profit of associated companies, net
|
34
|
38
|
||||||
|
Profit before income taxes
|
20
|
32
|
||||||
|
Income tax expense
|
(6
|
)
|
(7
|
)
|
||||
|
Profit for the period
|
14
|
25
|
||||||
|
Attributable to:
|
||||||||
|
Equity holders of the company
|
12
|
18
|
||||||
|
Non-controlling interest
|
2
|
7
|
||||||
|
Profit for the period
|
14
|
25
|
||||||
|
For the three months ended
March 31,
|
||||||||
|
2026
|
2025
|
|||||||
|
$ millions
|
||||||||
|
Cash flows (used in)/provided by operating activities
|
(15
|
)
|
65
|
|||||
|
Cash flows used in investing activities
|
(92
|
)
|
(87
|
)
|
||||
|
Cash flows provided by/(used in) financing activities
|
347
|
(12
|
)
|
|||||
|
Increase/(decrease) in cash and cash equivalents
|
240
|
(34
|
)
|
|||||
|
Cash and cash equivalents at beginning of the year
|
913
|
263
|
||||||
|
Effect of exchange rate fluctuations on balances of cash and cash equivalents
|
5
|
(4
|
)
|
|||||
|
Cash and cash equivalents at end of the period
|
1,158
|
225
|
||||||
|
|
As at
|
|||||||
|
|
March 31,
2026
|
December 31,
2025
|
||||||
|
|
$ millions
|
|||||||
|
Total financial liabilities1
|
2,281
|
1,769
|
||||||
|
Total monetary assets2
|
1,323
|
1,077
|
||||||
|
Investment in associated companies
|
1,348
|
1,626
|
||||||
|
Total equity attributable to the owners
|
2,288
|
2,028
|
||||||
|
Total assets
|
5,691
|
4,698
|
||||||
|
1.
|
Including loans from banks and others and debentures
|
|
2.
|
Including cash and cash equivalents, term deposits and restricted cash
|
|
For the three months ended
March 31,
|
||||||||
|
|
2026
|
2025
|
||||||
|
|
$ millions
|
|||||||
|
Profit for the period
|
14
|
25
|
||||||
|
Depreciation and amortization
|
26
|
19
|
||||||
|
Financing expenses, net
|
20
|
13
|
||||||
|
Income tax expense
|
6
|
7
|
||||||
|
EBITDA
|
66
|
64
|
||||||
|
Share in depreciation and amortization and financing expenses included within share in profit of associated companies, net
|
41
|
46
|
||||||
|
Changes in net expenses, not in the ordinary course of business and/or of a non-recurring nature
|
17
|
3
|
||||||
|
Adjusted EBITDA including proportionate share in associated companies
|
124
|
113
|
||||||